| 证券代码 | BLAC.O |
| 证券名称 | Bellevue Life Sciences Acquisition Corp |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2023-03-17 |
| 首发价格(元) | 10 |
| 首发数量(股) | 6000000 |
| 首发募资额(元) | 60,000,000.00 |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Bellevue Life Sciences Acquisition Corp. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 10900 NE 4th Street, Suite 2300, Bellevue, Washington, USA |
| 成立日期 | 2020-02-25 |
| 董事会主席 | Steven Reed |
| 公司属地 | United States 美国 |
| 公司网址 | - |
| 电话 | +1 (425) 635-7700 |
| 传真 | - |
| 公司简介 | Bellevue Life Sciences Acquisition Corp., is a newly organized blank check company incorporated in Delaware and formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which the company refer to throughout this prospectus as it's “initial business combination.” |